Human Prolactin Quantikine ELISA Kit

• Reactivity: Hu
• Applications: ELISA
• Conjugate: HRP

Human Prolactin Quantikine ELISA Kit Summary

• Background: The Quantikine Human Prolactin Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human Prolactin in serum and plasma. It contains E. coli-expressed recombinant human Prolactin and has been shown to accurately quantitate the recombinant factor. Results obtained using natural human Prolactin showed linear curves that were parallel to the standard curves obtained using th...e Quantikine kit standards. These results indicate that this kit can be used to determine relative mass values for naturally occurring Prolactin.
  Show More
• Specificity: Natural and recombinant human Prolactin and natural human macroprolactin
• Source: N/A
• Assay Type: Solid Phase Sandwich ELISA
• Inter-Assay: See PDF Datasheet for details
• Intra-Assay: See PDF Datasheet for details
• Spike Recovery: See PDF Datasheet for details
• Sample Volume: See PDF Datasheet for details
• Gene: PRL

Applications/Dilutions

• Dilutions:
  • ELISA
• Application Notes: Interference observed with 1 or more available related molecules.

Packaging, Storage & Formulations

• Storage: Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Human Prolactin Quantikine ELISA Kit

• PRL
• Prolactin

Background

Prolactin (PRL) is a neuroendocrine pituitary hormone that is synthesized by anterior pituitary, placenta, brain, uterus, dermal fibroblasts, decidua, B cells, T cells, natural killer cells, and breast cancer cells. The prolactin receptor is a transmembrane type I glycoprotein that belongs to the hematopoietic cytokine receptor family.

Prolactin receptor (PRL R) contains an extracellular, transmembrane, and intracellular domain. Transcriptional regulation of the PRL R gene results in several different species-dependent isoforms of PRL R being produced.

⚠ WARNING: This product can expose you to chemicals including N,N-Dimethylforamide, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

Publications for Prolactin (DPRL00)(5)

Publications using DPRL00

• SR Park, MG Kook, SR Kim, JW Lee, CH Park, BC Oh, Y Jung, IS Hong Development of cell-laden multimodular Lego-like customizable endometrial tissue assembly for successful tissue regeneration Biomaterials research, 2023-04-21;27(1):33. 2023-04-21 [PMID: 37085887] (Human)
• Y Fan, RWK Lee, XW Ng, CE Gargett, JKY Chan Subtle changes in perivascular endometrial mesenchymal stem cells after local endometrial injury in recurrent implantation failure Scientific Reports, 2023-01-05;13(1):225. 2023-01-05 [PMID: 36604485] (Human)
• AH Cincotta, E Cersosimo, M Alatrach, M Ezrokhi, C Agyin, J Adams, R Chilton, C Triplitt, B Chamarthi, N Cominos, RA DeFronzo Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects International Journal of Molecular Sciences, 2022-08-09;23(16):. 2022-08-09 [PMID: 36012132] (Human)
• M Gabrielson, S Azam, E Hardell, M Holm, KA Ubhayaseke, M Eriksson, M Bäcklund, J Bergquist, K Czene, P Hall Hormonal determinants of mammographic density and density change Breast Cancer Res., 2020-08-26;22(1):95. 2020-08-26 [PMID: 32847607] (Human)
• MN Stein, JR Bertino, HL Kaufman, T Mayer, R Moss, A Silk, N Chan, J Malhotra, L Rodriguez-, J Aisner, RD Aiken, BG Haffty, RS DiPaola, T Saunders, A Zloza, S Damare, Y Beckett, B Yu, S Najmi, C Gabel, S Dickerson, L Zheng, WS El-Deiry, JE Allen, M Stogniew, W Oster, JM Mehnert First-in-human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors Clin. Cancer Res, 2017-03-22;0(0):. 2017-03-22 [PMID: 28331050] (Human)

Bioinformatics

• Gene Symbol: PRL